HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2081048Generated: November 1, 2026
2,4-Dichlorobenzylamine → N-[(2,4-dichlorophenyl)methyl]-3-methyl-1-[4-(methyloxy)-2-pyrimidinyl]-2-oxo-4-imidazolidinecarboxamide
https://huagongshe.com/reaction/2081048
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2,4-Dichlorobenzylamine | HCID 1485 | — |
| Reactant | Ethylmorpholine | HCID 7525 | — |
| Reactant | 1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride | HCID 2723939 | — |
| Reactant | 1-Hydroxybenzotriazole hydrate | HCID 2796029 | — |
| Reactant | 3-Methyl-1-[4-(methyloxy)-2-pyrimidinyl]-2-oxo-4-imidazolidinecarboxylic acid | HCID 67103621 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | N-[(2,4-dichlorophenyl)methyl]-3-methyl-1-[4-(methyloxy)-2-pyrimidinyl]-2-oxo-4-imidazolidinecarboxamide | HCID 25095697 | 48.8% |
Reaction Steps
3-Methyl-1-[4-(methyloxy)-2-pyrimidinyl]-2-oxo-4-imidazolidinecarboxylic acid (76 mg, 0.3 mmol) (˜0.3 mmol) in dichloromethane (4 ml) was treated with the 4A molecular sieves (200 mg, 0.300 mmol), and the mixture stirred at RT for 5 minutes. N-Ethylmorpholine (0.190 ml, 1.500 mmol), 1-hydroxybenzotriazole hydrate (55.1 mg, 0.360 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (82 mg, 0.360 mmol) were then added and the reaction stirred at RT under argon for 10 minutes. [(2,4-Dichlorophenyl)methyl]amine (58.1 mg, 0.330 mmol) was added and the reaction left to stir at RT under argon for 4 hours. The reaction mixture was diluted with dichloromethane (15 ml) and saturated sodium hydrogen carbonate solution (20 ml), and the product was extracted into dichloromethane (×2). The combined organic extracts were washed with water (20 ml), brine (20 ml) and then dried over magnesium sulphate. The solvent was evaporated in vacuo to give a yellow solid, which was purified by mass-directed automated HPLC. Fractions containing product were combined and solvent evaporated in vacuo, co-evaporated with diethyl ether to give N-[(2,4-dichlorophenyl)methyl]-3-methyl-1-[4-(methyloxy)-2-pyrimidinyl]-2-oxo-4-imidazolidinecarboxamide as a white solid (60 mg, 46.3% yield). LC/MS [M+H]+=410, retention time 1.73=minutes.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07932282B2 |
|---|
| Source dataset | uspto-grants-2011_04 |
|---|
| ORD ID | ord-03c90663eb474397b443d503abe3601e |
|---|
| Source note | uspto-grants-2011_04 |
|---|